Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent
- 28 February 2013
- journal article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 60, 23-28
- https://doi.org/10.1016/j.ejmech.2012.11.039
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effectiveness of a patient‐ and practice‐level colorectal cancer screening intervention in health plan membersCancer, 2010
- Adjuvant targeted therapy in early breast cancerCancer, 2009
- Targeted therapies in breast cancerSeminars in Diagnostic Pathology, 2008
- Synthesis and antifungal activities of 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-thiadiazole and 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-oxadiazole derivativesBioorganic & Medicinal Chemistry, 2007
- Superior Reactivity of Thiosemicarbazides in the Synthesis of 2-Amino-1,3,4-oxadiazolesThe Journal of Organic Chemistry, 2006
- Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazolesBioorganic & Medicinal Chemistry Letters, 2005
- Synthesis and biological evaluation of novel 1β-methylcarbapenems having a new moiety at C-2Bioorganic & Medicinal Chemistry Letters, 1999
- synthesis of new Δ2-isoxazoline derivatives and their pharmacological characterization as β-adrenergic receptor antagonistsBioorganic & Medicinal Chemistry, 1998
- A survey of telomerase activity in human cancerEuropean Journal of Cancer, 1997
- Telomere loss: mitotic clock or genetic time bomb?Mutation Research/DNAging, 1991